My PCR
Create Account
Logo PCR

21 May 2021

Tricuspid / Pulmonary valve

EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!

Session comprising selected EuroPCR 2021 Hotlines & Late-Breaking Trials submissions

M. Eleid, M. Gavazzoni, S. Kodali, P. Lurz, G. Nickenig, R. S. von Bardeleben

Summary

Find out more about various studies & registries in TRICUSPID:

  • Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
  • Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
  • Clinical Response to Transcatheter treatment of tricuspid regurgitation: International TriValve registry
  • Baseline characteristics and procedure outcomes from TriClip bRIGHT study
  • Transfemoral tricuspid valve replacement: TRISCEND study 30-day results
  • 30-day outcomes for transcatheter tricuspid repair from the TriBAND study

Presentations available when logged in:

  • Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
  • Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
  • Clinical Response to Transcatheter treatment of tricuspid regurgitation
  • Baseline characteristics and procedure outcomes from TriClip bRIGHT study
  • Transfemoral tricuspid valve replacement: TRISCEND study 30-day results
  • 30-day outcomes for transcatheter tricuspid repair from the TriBAND study
Related Content
Abstract Book - PCR Gulf Valves 2025 Mastering tricuspid TEER - LIVE Case Integrating the newest valve guidelines into daily clinical reality
Recommended for you
Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines Is your research ready to submit? Join #PCRLV - Register now!